US Bancorp’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

US Bancorp’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$13.1K	–	4194
2023 Q3	$13.1K	Hold	10,000	–	–	﹤0.01%	3067
2023 Q2	$17.5K	Hold	10,000	–	–	﹤0.01%	3041
2023 Q1	$16.8K	Hold	10,000	–	–	﹤0.01%	3080
2022 Q4	$29.9K	Hold	10,000	–	–	﹤0.01%	2785
2022 Q3	$44K	Hold	10,000	–	–	﹤0.01%	2622
2022 Q2	$40K	Hold	10,000	–	–	﹤0.01%	2709
2022 Q1	$40K	Hold	10,000	–	–	﹤0.01%	2737
2021 Q4	$47K	Buy	+10,000	New	+$71K	﹤0.01%	2697

US Bancorp's MIRO Position: Q4 2023 in Review

US Bancorp sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 10,000 shares — an estimated $13.1K sold.

US Bancorp first reported a position in MIRO in Q4 2021 and held it in 8 quarters. The position peaked at $47K in Q4 2021. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

US Bancorp reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
US Bancorp sold 10,000 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $13.1K.
US Bancorp first reported a position in Miromatrix Medical Inc. Common Stock in Q4 2021 and held it in 8 quarters.
US Bancorp's Miromatrix Medical Inc. Common Stock position peaked at $47K in Q4 2021.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.